Einloggen
Einloggen
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrieren
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

MERCK & CO., INC.

(A0YD8Q)
  Bericht
Realtime-Estimate Cboe BZX  -  14:40:40 06.02.2023
102.98 USD   +0.04%
04:29Endometriumkarzinom-Kombination von Merck & Co. verlängert das progressionsfreie Überleben in einer Studie im Spätstadium
MT
03.02.Merck & Co., Inc. : Bewertung von Wells Fargo Securities kaufen
MM
03.02.Merck & Co., Inc. : Bewertung von Truist Securities kaufen
MM
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivateFonds 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-NewsMarketScreener Analysen
Nachrichten in anderen Sprachen über MERCK & CO., INC.
04:29Merck & Co.'s Endometrial Cancer Combo Extends Progression-free Survival in Late-stage ..
03.02.Nueva alerta de compra en la cartera Inversor EE.UU.
03.02.Alert: New purchase in the USA Investor Portfolio
03.02.Alerte Nouvel Achat dans le portefeuille Investisseur USA
03.02.Merck : un traitement a atteint le critère principal de survie
03.02.Merck Says Trial of Keytruda and Chemotherapy to Treat Endometrial Cancer Meets Primary..
03.02.Merck's Keytruda Meets Main Endpoints in Endometrial Carcinoma Study
03.02.Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy Met Primary Endpoint of Progression..
03.02.Merck Announces Phase 3 NRG-GY018 Trial Evaluating Keytrudav
03.02.Merck & Co. Flags Lower COVID-19 Drug Sales in FY23
02.02.Prospects of Fed's Rate-Hiking Cycle Ending Soon Lifts Equities
02.02.Global markets live: ABB, Infineon, Shell, Metlife, Boeing...
02.02.Merck Posts Mixed Fourth-Quarter Results, Issues Downbeat Full-Year Earnings Outlook
02.02.Merck sets 2023 earnings expectations below Street forecasts
02.02.No-surprise rate hikes
02.02.Sector Update: Health Care Stocks Mixed Pre-Bell Thursday
02.02.Les valeurs à suivre aujourd'hui à Wall Street - Jeudi 2 février 2023
02.02.Merck : performant au quatrième trimestre 2022 mais chute sur les prévisions de BP..
02.02.Merck fait mieux que prévu au 4ème trimestre
02.02.Merck Q4 Adjusted Earnings Slip, Sales Increase; Issues 2023 Outlook
02.02.Merck : 4Q22 Merck Earnings Presentation
02.02.Merck : hausse de 22% des ventes sur l'année 2022
02.02.Merck : Q4 Earnings Snapshot
02.02.Merck & Co., Inc. Provides Earnings Guidance for the Year 2023
02.02.GUIDANCE: (MRK) MERCK & CO. Expects Fiscal Year 2023 Revenue Range $57.2B - $58..
02.02.GUIDANCE: (MRK) MERCK & CO. Expects Fiscal Year 2023 EPS Range $6.80 - $6.95
02.02.Earnings Flash (MRK) MERCK & CO. Reports Q4 Revenue $13.83B
02.02.Earnings Flash (MRK) MERCK & CO. Posts Q4 EPS $1.62
02.02.Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results
02.02.Bolsa de Madrid: Powell, está confuso
02.02.En Direct des Marchés : BNP Paribas, Orange, Dassault Systèmes, Pu..
02.02.Powell, c'est flou
02.02.Merck & Co. Says No Direct Evidence of COVID-19 Pill Leading to New Variants
30.01.AstraZeneca Doses First Patient in Phase 3 Study of Datopotamab Deruxtecan to Treat Lun..
30.01.Daiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatment
30.01.Merck - FDA Approves KEYTRUDA as Adjuvant Treatment Following Surgical Resection and Pl..
27.01.Merck : la FDA approuve une nouvelle indication du Keytruda
27.01.Merck Says Keytruda Approved by FDA as Adjuvant Treatment for Non-Small Cell Lung Cance..
27.01.FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resecti..
27.01.Merck Announces the U.S. Food and Drug Administration has Approved KEYTRUDA
27.01.Merck & Co.'s Animal Health Unit Wins US FDA Nod for Expanded Use of Flea Drug for Dogs
26.01.Merck : a reçu une approbation de la FDA pour BRAVECTO
26.01.Merck Animal Health Division Says US FDA Approves Expanded Indication of Bravecto Chews..
26.01.Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO (flu..
26.01.Merck & Co.'s Keytruda Combo Prolongs Survival in Late-stage Biliary Tract Cancer Study
25.01.Merck : essai non-concluant dans le cancer de la prostate
25.01.Merck : Keytruda prometteur dans le cancer des voies biliaires
25.01.Merck to Cease Phase 3 Trial for Treatment of Prostate Cancer Due to Failure in Meeting..
25.01.Merck Reports Keytruda Phase 3 Success, Failure
25.01.Merck Announces KEYNOTE-991 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Enzalutamid..
25.01.Merck Announces KEYNOTE-991 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Enzalutamid..
25.01.Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Surv..
25.01.Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall..
24.01.Merck & Company Keeps Quarterly Dividend at $0.73 a Share; Payable April 10 to Holders ..
24.01.Merck Announces Second-Quarter 2023 Dividend
24.01.Merck Announces Dividend for the Second-Quarter of 2023 , Payable on April 10, 2023
24.01.Merck : Provides Update on Expenses Related to Recent Transactions
23.01.Genexine Receives Fast Track Designation from Korean Health Authority (MFDS) for its pr..
19.01.Evaxion Biotech Says Cancer Immunotherapy Candidate EVX-01, With Keytruda, Gets US FDA ..
18.01.Asher Bio Announces Dosing of First Patient in Phase 1a/1b Clinical Trial of AB248, a C..
18.01.Teon Therapeutics Announces Clinical Trial Collaboration with Merck to Evaluate Tt-816,..
18.01.Merck Picks Perceiv AI, Other Eight Biomedical Startups for Digital Technologies Progra..
18.01.Merck & Co. Aims To End Presence Of Potential Carcinogen In Diabetes Drugs By End-2023
18.01.Merck Selects Perceiv AI for Inaugural Digital Sciences Studio Cohort
18.01.Merck Selects Perceiv AI for Inaugural Digital Sciences Studio Cohort
17.01.Merck & Company Reportedly Can Remove Cancer-Causing Nitrosamines From Diabetes Drugs b..
17.01.Microsoft expands access to OpenAI tools, M&S inves..
16.01.Anglia Ruskin University Aru : The science behind the new mRNA cancer vaccines
16.01.PFIZER, MERCK : vers des transactions d'ampleur ?
16.01.The end of the 60/40 structure in portfolio managem..
16.01.Cronache di Borsa - Lunedì 16 gennaio
16.01.Crédit Suisse licencie, Bayer réoriente, Ford veut ..
16.01.Merck Named One of America's Most JUST Companies by JUST Capital and CNBC, Industry Lea..
13.01.Cancer Vaccine Trials Could Start in the in Autumn - UK Signs Deal With Biontech
12.01.Health Rounds: Artificial pancreas closer for type 2 diabetes
12.01.Merck Completes Tender Offer to Acquire Imago BioSciences, Inc
11.01.Insider Sell: Merck
11.01.Global markets live: Darktrace, Boeing, Tesla, Wells Fargo, Accentur..
11.01.The bulls are back in town
11.01.Merck Vows to Sue Unauthorized COVID Drug Distributors in China
11.01.Merck Named One of America's Most JUST Companies by JUST Capital and CNBC Industry Lead..
11.01.Merck & Company Concludes Cash Tender Offer to Acquire Imago BioSciences
11.01.Merck : les résultats de l'offre sur Imago BioSciences
11.01.Merck & Co. to Launch Legal Battle Against Unauthorized Chinese COVID-19 Drug Sellers
11.01.Merck Completes Tender Offer to Acquire Imago BioSciences, Inc.
11.01.Merck & Co. Said to Refuse China's Demand to Lower COVID-19 Drug Price
10.01.Merck Named One of America's Most JUST Companies by JUST Capital and CNBC, Industry Lea..
09.01.Nabriva Therapeutics Provides Corporate Update
06.01.Nabriva Therapeutics Approves Wind-Down Plan, Will Terminate All Non-Essential Employee..
05.01.Triumvira Immunologics Establishes Collaboration with Merck to Evaluate Tac01-Her2 Cell..
05.01.Merck to Hold Fourth-Quarter and Full-Year 2022 Sales and Earnings Conference Call Febr..
05.01.Nouscom Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluat..
04.01.Sector Update: Health Care Stocks Struggle for Direction on Wednesday
04.01.Sector Update: Health Care Stocks Mostly Higher in Recent Trading
04.01.Global markets live: Microsoft, Nvidia, Cisco, Salesforce, Rivian...
04.01.Immutep Enrolls 50% of Patients in Phase 2b Trial for Head, Neck Cancer Treatment
04.01.Merck : BofA relève son opinion
03.01.Merck to Present at the 41st Annual J.P. Morgan Healthcare Conference
2022Trending : Merck's Molnupiravir Approved for Emergency Use in China
2022Merck's COVID-19 Treatment Molnupiravir Approved for Emergy Use in China
Anstehende Termine für MERCK & CO., INC.